Application value of silver ion dressing in the treatment of chronic wounds in diabetic patients

董炜,唐佳俊,陆树良,周景祺,管皓楠

DOI: https://doi.org/10.3760/cma.j.cn115791-20210407-00195

2021-01-01

Abstract:Objective:To investigate the clinical efficacy of silver ion dressing in the treatment of chronic wounds in diabetic patients.Methods:A retrospective analysis of 60 diabetic patients with chronic refractory wounds admitted to our hospital and cooperative units between February 2018 and February 2019 was conducted. The patients were divided into the experimental group (silver ion dressing group) and the control group (silver sulfadiazine group) according to the wound treatment. According to the Bates-Jensen Wound Assessment Tool (BWAT), the wound healing, infection and healing time of the two groups were scored and compared. Statistical analysis was performed using Mann-Whitney U test, independent sample t test and χ2 and Fisher exact test. Results:(1) Wound situation. There was no significant difference in the BWAT scores of the two groups on the 7th and 14th days; on the 21st day, the BWAT score of the silver ion dressing group was significantly lower than that of the silver sulfadiazine group ( P<0.05). However, there was no significant difference in the BWAT% scores of the two groups on the 7th day; on the 14th and 21st days, the BWAT% score of the silver ion dressing group was significantly lower than that of the silver sulfadiazine group ( P<0.05). (2) Wound infection status. The BWAT-I scores of the two groups on the 1st and 7th days were significantly different ( P<0.05), and the silver ion dressing group was higher than the silver sulfadiazine group; there was no significant difference in the BWAT-I scores of the two groups on the 14th and the 21st days. There were significant differences in the BWAT-I% between the two groups on the 7th, 14th and 21st days ( P<0.05). The silver ion dressing group was significantly lower than the silver sulfadiazine group. (3) Wound healing time. The wound healing time of the silver ion dressing group [34.50 (22.75, 57.25) d] was significantly shorter than that of the silver sulfadiazine group [46.50 (37.75, 64.75) d], and the difference was statistically significant ( Z=-2.191, P<0.05). Conclusion:On the basis of thorough debridement, the topical application of silver ion dressing on chronic wounds in diabetic patients can effectively reduce and control wound infections and speed up the process of wound repair.